Blog

In summer heat, athletic trainers call for safety measures

By Randi Belisomo (Reuters Health) – A thousand-dollar expenditure for an automated external defibrillator (AED) could mean the difference between life and death for some young athletes, a cost that one Little Rock, Arkansas high school knows too well. A heart abnormality caused 16-year-old Antony Hobbs to collapse during his Parkview High basketball game in 2008. The outcome differed starkly two years later when another Parkview player, Chris Winston, collapsed

In summer heat, athletic trainers call for safety measures

By Randi Belisomo (Reuters Health) – A thousand-dollar expenditure for an automated external defibrillator (AED) could mean the difference between life and death for some young athletes, a cost that one Little Rock, Arkansas high school knows too well. A heart abnormality caused 16-year-old Antony Hobbs to collapse during his Parkview High basketball game in 2008. The outcome differed starkly two years later when another Parkview player, Chris Winston, collapsed

Valeant profit beats estimates as U.S. sales stay strong

(Reuters) – Drugmaker Valeant Pharmaceuticals International Inc reported a better-than-expected quarterly profit, helped by strength in its dermatology business in the United States, sending its shares higher in early trade. The Canadian company also raised its earnings and revenue forecasts for the year to reflect sales of recently acquired Salix Pharmaceuticals’ irritable bowel syndrome drug, Xifaxan. The U.S. Food and Drug Administration approved Xifaxan, also known as rifaximin, in May.

Valeant profit beats estimates as U.S. sales stay strong

(Reuters) – Drugmaker Valeant Pharmaceuticals International Inc reported a better-than-expected quarterly profit, helped by strength in its dermatology business in the United States, sending its shares higher in early trade. The Canadian company also raised its earnings and revenue forecasts for the year to reflect sales of recently acquired Salix Pharmaceuticals’ irritable bowel syndrome drug, Xifaxan. The U.S. Food and Drug Administration approved Xifaxan, also known as rifaximin, in May.

Activists urge U.S. states to pass laws banning FGM

By Maria Caspani NEW YORK (Thomson Reuters Foundation) – Rights activists have called on all U.S. states to adopt laws banning female genital mutilation (FGM), one year after the United States committed itself at a summit in London to eradicating the practice. The United States was one of more than 30 countries to sign a charter for the elimination of FGM and forced marriage, at home and abroad, at the